Does mutated K-RAS oncogene attenuate the effect of Sulindac in colon cancer chemoprevention?

The non-steroidal anti-inflammatory drug (NSAID) Sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition, and also showed its efficacy in prevention of sporadic colon adenomas. At the same time, some experi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Prev Res (Phila)
Main Authors: Rice, Photini FS., Ehrichs, Kevin G., Jones, Mykella S., Chen, Hwudarw, Hsu, Chiu-Hsieh, Abril, Edward R., Nagle, Raymond B., Besselsen, David G., Barton, Jennifer K., Ignatenko, Natalia A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7733710/
https://ncbi.nlm.nih.gov/pubmed/29118162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-17-0230
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados